Core Viewpoint - The stock price of China Nuclear International (02302.HK) surged significantly due to the explosive growth in the controlled nuclear fusion sector, marking a new high in nearly a decade [2][7][6]. Company Performance - In 2024, China Nuclear International achieved operating revenue and net profit attributable to shareholders of 1.705 billion yuan and 181 million yuan, representing year-on-year growth of 216.95% and 83.42% respectively [2][13]. - The company has shown strong performance growth from 2021 to 2023, with operating revenues of 232 million yuan, 811 million yuan, and 530 million yuan, and net profits of 2 million yuan, 72 million yuan, and 96 million yuan respectively [13]. Market Dynamics - The nuclear power industry is entering a decade-long golden development cycle, with the uranium market expected to face structural shortages [12]. - The global market for controlled nuclear fusion is projected to reach $496.5 billion by 2030 and may exceed $1 trillion by 2050 [11]. Investment Trends - The controlled nuclear fusion concept has gained significant attention, leading to a surge in capital investment, with private fusion companies globally raising a total of $7.12 billion by mid-2024, an increase of $900 million year-on-year [10]. - The domestic investment in controlled nuclear fusion experimental reactors is estimated to exceed 60 billion yuan, creating a demand for upstream component orders [12]. Stock Performance - On May 26, 2023, the stock price of China Nuclear International reached a peak of 5.10 HKD per share, a 186% increase from the previous closing price of 1.78 HKD, before closing at 4.09 HKD, a 129.78% increase [2][3][6]. - The stock price has returned to its highest level since June 3, 2015, indicating strong market interest [6][4].
中核国际经营向好净利1.8亿增83% 可控核聚变火爆盘中股价创10年新高